Montara Therapeutics, Inc.
Randall Chin, PhD, is a seasoned expert in the field of molecular biology, holding a Doctor of Philosophy degree from UCLA. Currently, Randall serves as the VP of Discovery at Montara Therapeutics, Inc., and previously worked as a Life Science Consultant in a stealth mode company. Prior experience includes roles at Mitokinin Inc., where Randall was Director of Biomarkers and led the Mitochondrial Biology Team, as well as serving as a Senior Scientist and Scientist II. Randall began the professional career at Alexion Pharmaceuticals, Inc. as an Industry Postdoctoral Scientist and has academic research experience as a Graduate Student Researcher at the Molecular Biology Institute at UCLA.
This person is not in any teams
Montara Therapeutics, Inc.
1 followers
We are Montara Therapeutics, a San Francisco–based precision-medicine neuroscience biotech startup. Our team boasts significant experience from successful biotech firms such as Mitokinin, Denali, and Soteria, supported by a world-class Scientific Advisory Board (SAB). We bring a new approach to tackling challenging established targets, along with unique experience in developing enzyme activators and domain expertise in mitophagy. Our mission is to create innovative therapies for diseases of the CNS, with a focus on precision medicine and genetically validated targets to enhance drug safety and efficacy.